Financial Reports Latest Updates Industry Maps Economic Calendar

BioLASCO (6662) Annual Reports

Q: Where can I download BioLASCO (6662) annual reports?

Every financial year on this page links straight to the PDF filed with the Market Observation Post System (MOPS), Taiwan's statutory disclosure platform.

Q: What is an investor conference?

The Taiwanese equivalent of an earnings call. Listed companies present quarterly results and file the presentation deck with MOPS, usually in both languages.

Listed on the Taipei Exchange (TPEx), classified under Healthcare. This page collects the company's annual reports, with files served directly by the Market Observation Post System (MOPS).

english presentations

2025

latest year

Company profile

Sector： All Healthcare stocks →
Listing date： 2019-03-26
Incorporated： 2001-05-10
Paid-in capital： NT$256m

Website：Official site ↗

Financial history

Revenue & profit

Quarterly · In mn (TWD)

Revenue 64.5 mn Net income 10.4 mn

Taiwan filings are cumulative; figures here are restated to single quarters.

Show table：Income statement

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	112	71.7	82.0	141	61.1	63.0	91.1	58.0	65.3	84.5	48.9	60.3	59.8	58.6	50.5	56.4	59.8	69.4	49.1	74.0	59.8	81.9	47.7	92.3	68.8	83.8	59.9	70.3	63.2	69.3	61.0	64.5
Gross profit	—	—	—	—	46.4	30.1	20.4	54.1	25.1	26.2	37.1	27.2	29.3	36.7	20.8	26.0	29.9	28.4	21.5	27.4	27.4	28.3	19.6	28.1	25.3	31.3	17.3	28.9	28.6	40.0	18.9	30.3	26.3	29.3	20.2	25.9
Operating income	—	—	—	—	34.0	9.45	5.94	38.3	13.4	13.2	22.8	14.3	15.0	25.5	8.69	12.3	16.4	16.5	8.77	13.4	13.2	13.9	6.91	14.0	12.0	17.8	3.96	15.2	13.3	23.3	4.80	14.9	11.9	16.4	6.22	11.3
Pre-tax income	—	—	—	—	32.9	9.27	4.66	38.0	14.1	11.9	22.2	14.0	16.9	25.4	8.82	13.3	17.6	16.7	8.66	14.0	14.8	15.7	8.58	17.3	14.0	22.1	4.40	11.3	15.1	24.1	5.58	15.9	10.3	17.8	6.88	12.8
Net income	—	—	—	—	26.3	7.41	3.73	30.4	11.3	9.52	17.8	11.2	13.5	20.3	7.06	10.7	14.1	13.4	6.93	11.0	11.8	12.6	6.87	13.8	11.2	17.8	3.52	9.07	12.1	19.3	4.41	12.9	8.11	17.0	5.37	10.4

Balance sheet

Quarterly · In mn (TWD)

Total assets 598 mn Total liabilities 170 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	258	278	219	238	229	242	370	391	343	367	320	325	290	316	310	313	275	296	297	304	267	287	274	288	270	290	255	245	208	249	229	233	201	211	207	221
Total assets	371	413	385	394	376	392	524	552	509	532	602	614	570	589	586	586	549	574	576	583	552	570	572	581	558	573	560	643	581	613	602	612	585	593	587	598
Current liabilities	59.3	113	50.3	75.0	33.2	41.9	54.9	96.2	38.1	51.8	46.3	91.8	47.0	52.5	48.0	40.4	44.6	50.1	46.0	83.5	43.9	56.4	46.9	85.9	57.4	60.1	50.0	86.9	39.0	68.1	87.5	93.9	54.8	53.7	88.5	95.2
Total liabilities	72.7	126	62.7	86.8	44.9	53.2	69.1	110	51.2	64.3	121	164	118	122	116	107	111	114	110	146	104	115	103	141	111	112	101	189	138	163	181	184	142	135	167	170
Equity	298	287	322	307	332	339	455	442	458	467	481	450	452	468	471	480	439	460	466	437	447	455	469	440	447	461	458	454	444	449	420	428	443	458	420	427

Cash flow

Quarterly · In mn (TWD)

Operating 17.1 mn Investing -1.41 mn Financing -3.25 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	—	—	—	—	48.0	15.0	2.04	19.9	21.7	84.7	22.5	8.41	18.0	24.7	18.4	12.9	7.85	31.8	1.09	0.05	16.4	27.2	-19.1	3.73	23.1	21.7	-7.47	0.99	31.5	31.9	-6.28	27.5	10.8	16.7	-0.67	17.1
Investing	—	—	—	—	4.94	-5.40	0.42	-18.1	-1.81	-2.24	-124	-3.35	-3.05	-0.4	-8.89	-0.48	-4.98	1.19	-0.43	-1.27	-11.9	-15.2	-8.68	0.06	-0.38	0.17	-27.5	-68.1	4.03	-6.01	-2.39	-14.8	-1.99	-1.19	-3.55	-1.41
Financing	—	—	—	—	-40.0	-0.25	106	-0.67	-48.2	-0.7	64.2	-0.77	-49.4	-1.75	-1.75	-1.75	-53.0	-1.49	-2.27	-1.91	-42.9	-1.55	-2.29	-1.94	-40.0	-1.94	-1.95	54.0	-45.1	-2.37	-2.01	-3.27	-42.1	-7.06	-3.32	-3.25
Cash at period end	131	97.2	54.9	61.6	74.5	83.9	192	193	165	247	209	213	179	201	209	220	170	201	200	196	158	169	138	140	123	143	106	93.0	83.3	107	96.1	106	72.3	80.7	73.2	85.6

Profitability

Quarterly · %

Gross margin 40.1% Operating margin 17.6% Net margin 16.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	41.5%	41.9%	24.9%	38.5%	41.0%	41.6%	40.7%	47.0%	44.9%	43.4%	42.5%	43.1%	50.0%	48.5%	42.5%	48.5%	45.8%	40.8%	39.9%	38.0%	42.4%	38.3%	36.3%	31.3%	41.6%	47.8%	31.5%	43.1%	41.6%	42.3%	33.0%	40.1%
Operating margin	—	—	—	—	30.4%	13.2%	7.3%	27.2%	22.0%	21.0%	25.0%	24.7%	22.9%	30.2%	17.8%	20.4%	27.4%	28.2%	17.4%	23.7%	22.1%	20.1%	14.1%	19.0%	20.1%	21.7%	8.3%	16.4%	19.4%	27.8%	8.0%	21.2%	18.8%	23.7%	10.2%	17.6%
Net margin	—	—	—	—	23.5%	10.3%	4.5%	21.6%	18.5%	15.1%	19.5%	19.4%	20.7%	24.0%	14.4%	17.7%	23.5%	22.8%	13.7%	19.6%	19.8%	18.1%	14.0%	18.7%	18.8%	21.8%	7.4%	9.8%	17.6%	23.1%	7.4%	18.3%	12.8%	24.6%	8.8%	16.1%

Returns & leverage

Quarterly · %

ROE 9.6% ROA 6.8% Debt ratio 28.5%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	18.1%	13.4%	13.6%	14.8%	11.2%	11.4%	13.4%	10.9%	11.1%	11.7%	9.7%	9.6%	9.9%	9.7%	9.3%	9.0%	10.3%	9.9%	10.9%	10.0%	9.3%	9.6%	9.7%	10.2%	11.1%	10.1%	9.3%	10.3%	9.6%
ROA	—	—	—	—	—	—	—	14.3%	11.9%	11.9%	12.3%	8.6%	9.6%	11.2%	8.8%	8.6%	9.3%	7.8%	7.7%	7.8%	7.8%	7.4%	7.4%	7.8%	8.0%	8.7%	8.2%	6.8%	7.5%	7.4%	7.7%	7.8%	7.7%	7.0%	7.3%	6.8%
Debt ratio	19.6%	30.5%	16.3%	22.0%	11.9%	13.6%	13.2%	19.9%	10.1%	12.1%	20.1%	26.8%	20.7%	20.6%	19.7%	18.2%	20.1%	19.8%	19.1%	25.0%	18.9%	20.2%	18.1%	24.2%	19.9%	19.5%	18.1%	29.4%	23.7%	26.6%	30.1%	30.1%	24.2%	22.8%	28.4%	28.5%

EPS

Quarterly · NT$

EPS NT$0.41

Show table：EPS

Item	2016Q4	2017Q2	2017Q4	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（NT$）	—	—	—	—	1.13	0.32	0.16	1.23	0.43	0.37	0.69	0.44	0.53	0.79	0.28	0.41	0.55	0.52	0.27	0.43	0.46	0.49	0.27	0.54	0.44	0.69	0.14	0.35	0.47	0.76	0.17	0.51	0.31	0.67	0.21	0.41

Revenue & profit

Year-to-date · In mn (TWD)

Revenue 126 mn Net income 15.8 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (TWD)

Total assets 598 mn Total liabilities 170 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (TWD)

Operating 16.4 mn Investing -4.96 mn Financing -6.57 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 36.7% Operating margin 14.0% Net margin 12.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 9.6% ROA 6.8% Debt ratio 28.5%

EPS

Year-to-date · NT$

EPS NT$0.62

Revenue & profit

Annual · In mn (TWD)

Revenue 263 mn Net income 42.4 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2019	2020	2021	2022	2023	2024	2025
Revenue	347	299	228	236	265	293	263
Gross profit	126	130	105	104	104	115	105
Operating income	70.9	77.6	53.9	49.3	50.8	55.7	48.0
Pre-tax income	68.7	78.5	56.4	53.1	62.0	54.9	49.6
Net income	55.0	62.8	45.1	42.3	49.7	44.0	42.4

Balance sheet

Annual · In mn (TWD)

Total assets 593 mn Total liabilities 135 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2019	2020	2021	2022	2023	2024	2025
Current assets	367	316	296	287	290	249	211
Total assets	532	589	574	570	573	613	593
Current liabilities	51.8	52.5	50.1	56.4	60.1	68.1	53.7
Total liabilities	64.3	122	114	115	112	163	135
Equity	467	468	460	455	461	449	458

Cash flow

Annual · In mn (TWD)

Operating 48.7 mn Investing -20.3 mn Financing -54.5 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2019	2020	2021	2022	2023	2024	2025
Operating	128	73.5	70.8	44.7	29.5	56.9	48.7
Investing	-21.7	-131	-13.2	-28.7	-8.83	-97.6	-20.3
Financing	56.3	12.3	-58.0	-48.6	-46.2	4.59	-54.5
Cash at period end	247	201	201	169	143	107	80.7

Profitability

Annual · %

Gross margin 39.9% Operating margin 18.3% Net margin 16.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2019	2020	2021	2022	2023	2024	2025
Gross margin	36.3%	43.6%	46.2%	44.3%	39.4%	39.2%	39.9%
Operating margin	20.4%	25.9%	23.7%	20.9%	19.2%	19.1%	18.3%
Net margin	15.9%	21.0%	19.8%	17.9%	18.8%	15.1%	16.1%

Returns & leverage

Annual · %

ROE 9.3% ROA 7.0% Debt ratio 22.8%

Show table：Returns & leverage

Item	2019	2020	2021	2022	2023	2024	2025
ROE	11.8%	13.4%	9.7%	9.3%	10.9%	9.7%	9.3%
ROA	10.3%	11.2%	7.8%	7.4%	8.7%	7.4%	7.0%
Debt ratio	12.1%	20.6%	19.8%	20.2%	19.5%	26.6%	22.8%

EPS

Annual · NT$

EPS NT$1.66

Show table：EPS

Item	2019	2020	2021	2022	2023	2024	2025
EPS（NT$）	2.19	2.45	1.76	1.65	1.94	1.72	1.66

Source: Taiwan MOPS financial statements

BioLASCO annual reports

	English	Chinese
2025 (ROC 114)	Chinese only	PDF
2024 (ROC 113)	Chinese only	PDF

2 of the 2 financial years listed above have no English edition. Taiwanese issuers below a certain size are not required to file one; the Chinese PDF is linked instead so the year is not simply missing.

About BioLASCO filings

Where can I download BioLASCO (6662) annual reports?

Every financial year in the table above links straight to the PDF filed with the Market Observation Post System (MOPS), Taiwan's statutory disclosure platform.

Why are some years Chinese only?

Filing an English annual report is only mandatory for larger Taiwanese issuers; smaller companies and those on the Emerging Stock Board file in Chinese. Where no English edition exists this site links the Chinese PDF rather than leaving the year blank, so you can still reach the document.

What is an investor conference (法人說明會)?

It is the Taiwanese equivalent of an earnings call or analyst briefing. Listed companies present quarterly results and outlook, and file the presentation deck with MOPS — usually in both Chinese and English. Many also publish a webcast recording.

How does Taiwan's reporting calendar work?

Taiwanese issuers file quarterly financial reports plus an annual report, and publish monthly revenue figures — a disclosure cadence that is more frequent than Hong Kong or Singapore. Financial years are numbered using the ROC calendar (ROC 114 = 2025); this site shows both.

Source: Market Observation Post System (MOPS), Taiwan. All PDF links point to the original files; nothing is re-hosted here.
Browse all Taiwan listed companies, or read this page in Chinese — the Chinese edition also carries the letter to shareholders and the revenue breakdown.